Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: KEGG:D02003 (
NBT
)
1,323
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We described previously that acidic fibroblast growth factor (aFGF), but not basic fibroblast growth factor (bFGF), can induce the rat carcinoma cell line
NBT
-II to undergo a rapid and reversible transition from epithelial to mesenchymal phenotype (EMT). We now find that
NBT
-II EMT is stimulated by
keratinocyte growth factor
(
KGF
) in cells grown at low density. Accordingly, a high-affinity receptor showing 98% homology to mouse FGF receptor 2b/
KGF
receptor was cloned and sequenced from
NBT
-II cells. Northern analysis indicated that mRNA for FGF receptor 2b/
KGF
receptor was drastically down-regulated within 1 wk in aFGF-induced mesenchymal
NBT
-II cells. This decrease coincided with an up-regulation of FGF receptor 2c/Bek, a
KGF
-insensitive, alternatively spliced form of FGF receptor 2b/
KGF
receptor. Functional studies confirmed that
KGF
could not maintain EMT induction on mesenchymal
NBT
-II cells. FGF receptor 1 and FGF receptor 2c/Bek could also support EMT induction when transfected into
NBT
-II cells in response to aFGF or bFGF. Such transfected cells could bind bFGF as well as aFGF. Therefore, EMT can be induced through different FGF receptors, but EMT may also regulate FGF receptor expression itself.
...
PMID:Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells. 780 53